a Nanomedicine Research Unit, Department of Pharmaceutics, College of Pharmacy , King Saud University , Riyadh , Saudi Arabia.
b Department of Bioscience , Shri Ram Group of College (SRGC) , Muzaffarnagar , India.
Crit Rev Clin Lab Sci. 2019 Jan;56(1):1-17. doi: 10.1080/10408363.2018.1517144. Epub 2018 Oct 29.
Hosts and microbes have co-evolved over millions of years. Inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic immune-mediated diseases. Although the etiology of IBD remains an enigma, various studies have proposed the involvement of mucosa-associated Escherichia coli (E. coli) strains in the pathogenesis of IBD. E. coli, a usual inhabitant of the intestine, causes disease after acquiring virulence factors; however, the mechanisms underlying this phenomenon are not well understood. In the present review, we will discuss recent findings on how gut E. coli regulates and controls gut homeostasis and the pathogenesis of IBD. We will also summarize current knowledge regarding the cause, mechanism, genetics, and environmental factors involved in the regulation of IBD. Furthermore, we will discuss the possibility of alterations in innate and acquired immunity during the course of disease as well as possible treatment.
宿主和微生物在数百万年的时间里共同进化。炎症性肠病(IBD),包括克罗恩病(CD)和溃疡性结肠炎(UC),是慢性免疫介导的疾病。尽管 IBD 的病因仍然是个谜,但各种研究提出了粘膜相关大肠杆菌(E. coli)菌株在 IBD 发病机制中的作用。大肠杆菌是肠道的常见居民,在获得毒力因子后会引起疾病;然而,这一现象的机制尚不清楚。在本综述中,我们将讨论最近关于肠道大肠杆菌如何调节和控制肠道内稳态以及 IBD 发病机制的发现。我们还将总结目前关于调节 IBD 的原因、机制、遗传学和环境因素的知识。此外,我们将讨论在疾病过程中先天和获得性免疫可能发生的改变以及可能的治疗方法。
Crit Rev Clin Lab Sci. 2018-10-29
Clin J Gastroenterol. 2018-2
Inflamm Bowel Dis. 2018-5-18
World J Gastroenterol. 2015-10-28
Gut. 2017-11-15
Scand J Gastroenterol. 2015-1
Front Microbiol. 2024-2-14
Biomolecules. 2024-1-10
Front Microbiol. 2023-10-18
Hum Vaccin Immunother. 2023-8